Ulthera Report issue

For profit
Founded: Mesa AZ United States (2004)
Status: Acquired by Merz (2014)

Organization Overview

First Clinical Trial
2011
NCT01422538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ulthera, Inc

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 7